HB8 Supper Club: Sally Allain, Head of JLABS @Washington, DC
Virtual - Zoom
Wednesday, March 31, 2021
5:00 PM - 6:00 PM
Add to Calendar
Johnson & Johnson Innovation – JLABS is a global network of open ecosystems, enabling and empowering innovators across pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform.
JLABS @ Washington, DC, located at the new Children’s National Research & Innovation Campus will be the newest JLABS to open its doors in April.
The HBA Los Angeles Chapter is excited to host a discussion with Sally Allain – Head of JLABS @Washington, DC – about their collaboration with Children’s National and BARDA and what they’re doing at this state-of-the-art site in Washington, DC.
Sally will also share her experiences and thoughts on navigating the healthcare industry, perspectives on the state of the industry, and the allies she has chosen to support her along the way.
As Head of JLABS @ Washington, DC, Sally sets the strategic direction and oversees all operational activities for JLABS in the region. In this role, Sally is responsible for the process of evaluating and selecting a strong portfolio of innovators for JLABS @ Washington, DC, and building strategic partnerships with corporate, academic, government and industry organizations that aim to strengthen the region’s life sciences innovation network.
Sally understands well the needs of healthcare entrepreneurs, having launched her research career at a San-Diego based biotech startup and then working internationally for a UK-based governmental economic development agency creating early-stage biotech and academic collaborative programs aimed at accelerating the development of products to address the needs of patients and consumers.
Sally received her MBA from the University of California Berkeley, Haas School of Business, where she was recognized by ‘Poets and Quants’ as one of the ‘Top 50’ EMBA students across US & International Programs in 2016; a Master of Science Degree in Microbiology / Immunology from Virginia Tech; and a Bachelor of Science Degree in Biology from Virginia Tech.